Status:
NOT_YET_RECRUITING
Telerehabilitation in Central and Peripheral Neurological Sequelae From Chemotherapy
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Collaborating Sponsors:
Astir S.r.l.
Conditions:
Chemotherapy-induced Neurotoxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to validate the use of innovative tele-rehabilitation (TR) models in terms of efficiency and effectiveness in a pilot cohort of subjects with central and peripheral ...
Eligibility Criteria
Inclusion
- Adult subjects (\>18 years old) with central and/or peripheral neurotoxic sequelae following a history of cancer treated with chemotherapeutic agents (Cisplatin and Taxanes), in accordance with the criteria of the International Cognitive Cancer Task Force (Wefel et al., 2011. 10.1016/S1470-2045(10)70294-1)
- agreement to participate with the signature of the informed consent form;
Exclusion
- Ongoing chemotherapy treatment;
- Pre-existing neurological or psychiatric comorbidities (e.g., epilepsy, post-stroke disability, neurodegenerative diseases, genetically based polyneuropathy);
- Severe visual or hearing impairments that could interfere with the use of technology;
- Severe cognitive impairment (Mini-Mental State Examination score \<18);
- Severe postural disability associated with a high risk of falling at home, as documented in the clinical evaluation;
- Contraindications to undergoing MRI examination;
- Ongoing rehabilitation treatment.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07159854
Start Date
September 1 2025
End Date
August 31 2026
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Fondazione Don Carlo Gnocchi ONLUS
Milan, Italy, 20148